 BioMed Conference Israel 2006
May 29, 2006 | Jerusalem, Israel
Jacob Gelt Dekker and Eliezer Naaman participated in the BioMed Israel 2006 conference and Brokerage Event. Mr. Gelt Dekker represented the Jacob Gelt Dekker Institute for Advanced Cultural Studies as well as the Jade Foundation.
Eiliezer Naaman represented NAAMAN Executive Search & Consultancy Intl.. They will also visit the archaeological projects in Jerusalem of Prof. Rony Raich and of Prof. Elat Mazo.
A visit to the archaeological project of Prof. Finkelstein
in Megiddo is planned the same week.
Visit the Conference website
Dear Colleagues,
It is our honor and pleasure to invite you to participate in Biomed Israel 2006, to be held in Jerusalem from May 29-31, 2006.
This year's event, Biomed Israel 2006, follows the success of the previous annual Biotech Israel conferences. Notably, last year Biotech Israel was fortunate to host world renowned keynote speakers including Nobel Laureate Aaron Ciechanover, Prof. Leroy Hood, Founder of The Institute for Systems Biology, Mr. Fredrick Frank Vice Chairman of Lehman Brothers, Steven Burril of Burril & Co and Dr. Murray Lumpkin, Acting Deputy Commissioner of the US FDA. Over 2000 scientist, engineers and businesspeople participated in the conference, with over 400 participants from abroad.
After last year's event, the Biotech Israel organizing committee decided to integrate the vibrant and successful Israeli medical device sector into the annual conference. This commitment is reflected in the change of name from Biotech Israel to Biomed Israel. With this change, the organizing committee is committed to making the Biomed Israel conference the annual general meeting and showcase of the entire Israeli life sciences industry. This new broader focus creates a unique opportunity for everyone involved in our industry to meet and network, and for visitors from abroad to become acquainted with the entire life sciences industry in Israel at one high quality event.
Allow us to point out major planned events:
Therapeutic Sessions: Following the success of last year, the program will include three sessions dedicated to therapeutic areas, Cardiology, Orthopedics and Nerve Stimulation. Keynote Speakers will discuss innovations in science and technology. Diagnostic: Two sessions will be dedicated to Biomarkers and Imaging. We believe that these two areas are key to drug developments and will play a major role in the future trend for personalized medicine. The ?Healthcare Beyond 2010? session will close the conference. This topic will be covered by presentations and roundtable discussions involving scientists and pharma executives. Last but not least of course, our participants from abroad will have the opportunity to visit our beautiful country during the spring.
We look forward to your support and participation, and will provide more information and details as the conferences take shape.
Sincerely,
Aharon Schwartz, Ph.D
Co-Chairperson
Rafi Hofstein,Ph.D
Co-Chairperson
BioMed Israel 2006
Medical Knowledge Institute presents first Bob Pinedo Prize
Medical Knowledge Institute presents first Bob Pinedo Prize to Dr. Bruce Chabner at VUmc/MKI Oncology Symposium
Oostvoorne, the Netherlands, 5 September - On Thursday the 12 th of October the first international Oncology Symposium will be held at the VU University Medical Centre (VUmc) in Amsterdam. During this symposium the first Bob Pinedo Prize will be awarded by the Medical Knowledge Institute (MKI), a young, international non-profit organization that considers healthcare to be a fundamental human right. The prize has been initiated this year by the MKI to honor Bob Pinedo's work as founder of the VUmc CCA (Cancer Centre Amsterdam) and his efforts in cancer research, patient care and education. Professor Dr. H.M. (Bob) Pinedo has been closely associated to the MKI concerning cancer programs in emerging and transitional countries.
During a festive session, the Medical Knowledge Institute will award the ‘Bob Pinedo Prize for Contributions to Improvement in the Care of Cancer Patients' to Dr. Bruce A. Chabner for his exceptional contribution to improved care for cancer patients. Chabner is Clinical Director and Chief of Hematology/Oncology at the Massachusetts General Hospital Cancer Center in Boston and Professor of Medicine at Harvard Medical School. The Prize consists of an amount of 50,000 Euro (about $ 64,000) and a bronze statue in the form of one of Pinedo's hands, symbolizing strength and hope of healing.
The Oncology Symposium will also celebrate the opening of the research building at the VUmc CCA. This year's program will feature contributions by leading American cancer researchers like Dr. Judah Folkman, Dr. Daniel Von Hoff and Dr. James Allison. Dr. H.M. (Bob) Pinedo himself will also contribute with a presentation. Several researchers of the VUmc CCA will make scientific contributions from their own research programs as well.
The symposium and award ceremony will be yearly events. For more information and to register for the Oncology Symposium: www.cancercenteramsterdam.nl . Nominations for the Bob Pinedo Prize 2007 can be sent to PinedoPrize@infomki.org . Deadline for submitting nominations is: Monday April 23 rd 2007. All nominees will be evaluated by an international ‘nominating committee' that will also select the winner.
About the Medical Knowledge Institute
The Medical Knowledge Institute (MKI) is a non-profit healthcare education and healthcare information organization dedicated to the premise that healthcare is truly a human right, both in industrialized or developing and transitioning countries. The programs of MKI are designed to improve the quality of and to promote humanitarian values in healthcare through education and public health programs. The educational and information tools to confront related matters come from experts who are leaders in their healthcare fields. They offer information and guidance honed by experience. Our faculty is drawn from some of the finest institutions around the world.
The Medical Knowledge Institute is based in the Netherlands (Oostvoorne) and was founded in 1999 by Dr. Harold E. Robles, founder and President Emeritus of the Albert Schweitzer Institute for the Humanities, and Dr. Peter J. Bittel, Chairman and CEO of The Futures Health Group.
One of the many successful initiatives of the MKI is the HIV and AIDS Training Program aimed at preventing vertical transmission of HIV/AIDS in South-Africa; a recent project in cooperation with the International Confederation of Midwives (ICM), VU Medical Center in Amsterdam and the Dutch Red Cross. This training program is aimed at informing and educating midwives and healthcare workers on how to prevent the transmission of HIV/AIDS from mother to child. This can contribute to a major reduction in the number of HIV-infected newly borns in developing countries, concluded the four initiators in June 2006 after completing the first stage of a trial project in South-Africa.
More information about the activities, projects, workshops and events of the MKI:
www.infomki.org
|
